LYVE1 anticorps (AA 24-232) (Biotin)
Aperçu rapide pour LYVE1 anticorps (AA 24-232) (Biotin) (ABIN126136)
Antigène
Voir toutes LYVE1 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 24-232
-
Specificité
- The antibody recognizes LYVE-1.
-
Purification
- Antigen Affinity Chromatography.
-
Immunogène
- Recombinant Human soluble LYVE-1 (24-232) produced in insect cells. Remarks: The recombinant soluble LYVE-1 consists of amino acid 24 (Ser) to 232 (Gly) and is fused to a C-terminal His-tag (6xHis).
-
-
-
-
Indications d'application
-
The unconjugated antibody can be used for ELISA experiments, Western blotting, FACSand Cell Sorting (Use at 2-5 μg/mL together with the appropriate secondary reagents).
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user. -
Restrictions
- For Research Use only
-
-
-
Reconstitution
- Restore with sterile water to a concentration of 50 μg/mL
-
Buffer
- 0.1 M Tris-Cl, 0.1 M NaCl, pH 7.4 containing 0.02 % Sodium Azide as preservative and 50x BSA as stabilizer.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Conseil sur la manipulation
- Avoid repeated freezing and thawing. This product is photosensitive and should be protected from light.
-
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store the antibody undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
-
- LYVE1 (Lymphatic Vessel Endothelial Hyaluronan Receptor 1 (LYVE1))
-
Autre désignation
- LYVE-1
-
Sujet
- LYVE-1 has been identified as a major receptor for HA (extracellular matrix glycosaminoglycan hyaluronan) on the lymph vessel wall. The deduced amino acid sequence of LYVE-1 predicts a 322-residue type I integral membrane polypeptide 41 % similar to the CD44 HA receptor with a 212-residue extracellular domain containing a single Link module the prototypic HA binding domain of the Link protein superfamily. Like CD44, the LYVE-1 Molecule binds both soluble and immobilized HA. However, unlike CD44, the LYVE-1 Molecule colocalizes with HA on the luminal face of the lymph vessel wall and is completely absent from blood vessels. Hence, LYVE-1 is the first lymph-specific HA receptor to be characterized and is a uniquely powerful marker for lymph vessels themselves.Synonyms: CRSBP-1, CRSBP1, Cell surface retention sequence-binding protein 1, Extracellular link domain-containing protein 1, HAR, Hyaluronic acid receptor, LYVE1, Lymphatic vessel endothelial hyaluronic acid receptor 1, XLKD1
-
ID gène
- 10894
-
NCBI Accession
- NP_006682
-
UniProt
- Q9Y5Y7
-
Pathways
- Glycosaminoglycan Metabolic Process
Antigène
-